AU4496499A - Dna coding for gdnf, parts of said dna and gdnf variants - Google Patents

Dna coding for gdnf, parts of said dna and gdnf variants

Info

Publication number
AU4496499A
AU4496499A AU44964/99A AU4496499A AU4496499A AU 4496499 A AU4496499 A AU 4496499A AU 44964/99 A AU44964/99 A AU 44964/99A AU 4496499 A AU4496499 A AU 4496499A AU 4496499 A AU4496499 A AU 4496499A
Authority
AU
Australia
Prior art keywords
gdnf
dna
parts
variants
coding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44964/99A
Inventor
Lena Grimm
Elke Holinski-Feder
Thomas Meitinger
Marius Ueffing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Maximilians Universitaet Muenchen LMU
Original Assignee
Ludwig Maximilians Universitaet Muenchen LMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Maximilians Universitaet Muenchen LMU filed Critical Ludwig Maximilians Universitaet Muenchen LMU
Publication of AU4496499A publication Critical patent/AU4496499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AU44964/99A 1998-04-14 1999-04-14 Dna coding for gdnf, parts of said dna and gdnf variants Abandoned AU4496499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19816186 1998-04-14
DE1998116186 DE19816186A1 (en) 1998-04-14 1998-04-14 GDNF-encoding DNA, parts thereof and GDNF variants
PCT/DE1999/001111 WO1999053091A2 (en) 1998-04-14 1999-04-14 Dna coding for gdnf, parts of said dna and gdnf variants

Publications (1)

Publication Number Publication Date
AU4496499A true AU4496499A (en) 1999-11-01

Family

ID=7864285

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44964/99A Abandoned AU4496499A (en) 1998-04-14 1999-04-14 Dna coding for gdnf, parts of said dna and gdnf variants

Country Status (4)

Country Link
EP (1) EP1086220A2 (en)
AU (1) AU4496499A (en)
DE (1) DE19816186A1 (en)
WO (1) WO1999053091A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1463530A4 (en) * 2001-12-19 2006-09-06 Lijun Wang Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
FI20070808A0 (en) * 2007-10-25 2007-10-25 Mart Saarma Split variants of GDNF and uses thereof
EP2067858A1 (en) 2007-12-07 2009-06-10 Universidad de Sevilla Animal models for neurodegenerative diseases
UA112981C2 (en) * 2011-04-11 2016-11-25 Елі Ліллі Енд Компані OPTION OF HUMAN GDNF

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU220795B1 (en) * 1991-09-20 2002-05-28 Amgen Inc. Glialcell derived neurotrophic factor proteins and devices and pharmaceutical preparations for preventing and treating neural cell damage
US5585237A (en) * 1993-10-25 1996-12-17 Creative Biomolecules, Inc. Methods and compositions for high protein production from recombinant DNA
WO1995017203A1 (en) * 1993-12-22 1995-06-29 The University Of Medicine And Dentistry Of New Jersey Novel nucleic acid sequences isolated from glial cells
FR2717824B1 (en) * 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Recombinant viruses, preparation and use in gene therapy.
US6184200B1 (en) * 1995-09-28 2001-02-06 Amgen Inc. Truncated glial cell line-derived neurotrophic factor
PT888385E (en) * 1996-03-14 2004-01-30 Genentech Inc UTILIZATIONS OF GDNF AND GDNF RECEPTORS
NZ329482A (en) * 1996-03-14 2000-05-26 Univ Washington A growth factor persephin related to the GDNF/neurturin family of growth factors Methods of treating conditions related to persephin deficiency detecting gene alterations and identifying other members of the family are included
US6455277B1 (en) * 1996-04-22 2002-09-24 Amgen Inc. Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides
AU2677797A (en) * 1996-04-25 1997-11-12 Genetic Therapy, Inc. Viral vectors including polynucleotides encoding neurotrophic factors and uses therefor
AU6975198A (en) * 1997-04-15 1998-11-11 University Of Medicine And Dentistry Of New Jersey Cdna for human gdnf and promoter therefor which allows regulated and constitutive expression
WO1998053069A2 (en) * 1997-05-20 1998-11-26 Human Genome Sciences, Inc. Gdnf receptors
CA2290426A1 (en) * 1997-05-22 1998-11-26 Carlos F. Ibanez Glial cell line-derived neurotrophic factor receptors
AU7165998A (en) * 1997-05-30 1998-12-30 Amgen, Inc. Neurotrophic factor receptors
ATE360066T1 (en) * 1997-08-05 2007-05-15 Hoffmann La Roche HUMAN GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR PROMOTER, VECTORS CONTAINING SAME, AND METHODS FOR SCREENING CONNECTIONS THEREOF
AU749454B2 (en) * 1997-09-09 2002-06-27 Stryker Corporation Synergistic effects of OP/BMP morphogens and GDNF/NGF neurotrophic factors

Also Published As

Publication number Publication date
WO1999053091A9 (en) 1999-12-02
WO1999053091A3 (en) 2000-03-30
EP1086220A2 (en) 2001-03-28
DE19816186A1 (en) 1999-10-21
WO1999053091A2 (en) 1999-10-21

Similar Documents

Publication Publication Date Title
AU6497600A (en) Peracid forming system, peracid forming composition, and methods for making and using
AU4498500A (en) Phytyl/prenyltransferase nucleic acids, polypeptides and uses thereof
AU2434199A (en) Protein
EP1072266B8 (en) Thienylazolylalcoxyethanamines, their preparation and their application as medicaments
HUP0100847A3 (en) Novel aromatic amides, preparation method and application as medicines
WO2000018212A8 (en) Platelet-derived growth factor c, dna coding therefor, and uses thereof
AU1409100A (en) Drugs
AU1772399A (en) Well treatment
AU5587799A (en) Protein transport-associated molecules
AU3627899A (en) Coagulator
AU2587399A (en) Human transport-associated molecules
AU4496499A (en) Dna coding for gdnf, parts of said dna and gdnf variants
AU4198899A (en) Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process
AU3820699A (en) Catalyst and process for its preparation
AU3455000A (en) Composition for decomposing protein
AU3955099A (en) Novel gene and protein encoded thereby
AUPP243898A0 (en) Two-part clip
AU6289199A (en) Sulfotransferase sequence variants
AU1577100A (en) Catalytic process
AU4834799A (en) Human az-1 gene, variants thereof and expressed gene products
AU5196699A (en) Novel gene and protein pgth encoded thereby
AU3153199A (en) Azacycloalkane derivatives, preparation and therapeutic application
AU2965199A (en) Medicine mini-chest
AU5314999A (en) Modified oligonucleotides
AU5524399A (en) Inorgasmia treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase